Stay updated with breaking news from Nexstim oy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. FDA granted Neuronetics Inc. clearance for use of its Neurostar advanced therapy as an adjunctive treatment of major depressive disorder in patients aged 15 to 21, making it the first transcranial magnetic stimulation treatment (TMS) cleared for this age group, the company said. ....